US Trade & Commerce Research Institute Selects Telemedicine Industry Leader for Award

SCOTTSDALE, Ariz.--The US Trade and Commerce Research Institute (USTCRI) has selected Scottsdale-based GlobalMed® – the worldwide leader in telemedicine delivery systems - as the recipient of its 2013 Arizona Excellence Award which recognizes the commitment and contribution of small businesses through community and customer service.

GlobalMed’s telemedicine solutions are transforming healthcare globally by providing remote access to quality healthcare in order to improve outcomes while holding down costs.

In announcing the award, the USTCRI praised GlobalMed for consistently demonstrating a high regard for upholding business ethics and company values. The recognition by the USTCRI marks a significant achievement and designates GlobalMed as an emerging leader among Connected Health companies.

“We truly value our customers here in Arizona and around the world, and we believe that Arizona is a great place to headquarter our company,” said Joel E. Barthelemy, CEO and Founder of GlobalMed. “Service to our more than 50 healthcare centers in Arizona and thousands more in nearly 40 countries happens from our campus in Scottsdale.”

GlobalMed was chosen based on an exhaustive process of industry research and business surveys that encapsulates the USTCRI’s year-long immersion in the business climate of Arizona.

About USTCRI

The USTCRI is a leading authority on researching, evaluating and recognizing companies across a wide spectrum of industries that meet its stringent standards of excellence. It has spearheaded the idea of independent enterprise and entrepreneurial growth allowing businesses of all sizes to be recognized locally and encouraged globally. Particular emphasis is given to meeting and exceeding industry benchmarks for customer service, product quality and ethical practices. Industry leading standards and practices have been developed and implementation of the same has been pioneered by the dedicated efforts of the business community and commerce leadership.

About GlobalMed

GlobalMed develops integrated telemedicine solutions for healthcare providers and corporate health programs. GlobalMed’s broad array of connected medical devices and patient data workflow systems enable complete patient encounters from the patient location and the doctor to anywhere around the world, across a full range of healthcare specialties. For more information, visit www.globalmed.com or call 1-800-886-3692

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.